Hundreds of people who said they were injured by the popular cholesterol drug Crestor sued maker AstraZeneca. Those lawsuits have all been dismissed, withdrawn or quietly settled. A whistleblower lawsuit filed by former AstraZeneca employees was still pending in Texas in March 2018.
* UPDATE: Courts dismissed most Crestor lawsuits. The rest were settled or withdrawn. Drugwatch’s legal partners are not accepting Crestor cases at this time.
Lawsuits blamed Crestor for serious side effects. These include kidney damage, liver damage, severe muscle injury and Type 2 diabetes.
Crestor users filed more than 1,200 lawsuits in California state courts. Judges dismissed more than 1,000 of those lawsuits filed by out-of-state plaintiffs.
AstraZeneca released a financial report on Feb. 2, 2018. The report said the company resolved all product liability claims involving Crestor. The company didn’t disclose any further information.
Four former AstraZeneca employees filed whistleblower lawsuits in 2013 against the company. The Texas attorney general joined the consolidated case. As of March 2018, that lawsuit was still pending in Travis County, Texas.
Drugwatch’s legal partners are not accepting cases involving Crestor. But this could change in the future.
Status of Crestor Lawsuits
Hundreds of patients filed lawsuits blaming Crestor for injuries. California courts dismissed the vast majority of those lawsuits.
According to AstraZeneca, it has resolved all product liability lawsuits involving Crestor.
Injuries Mentioned in Crestor Lawsuits
Patients who sued AstraZeneca blame Crestor for various serious conditions. These injuries include diabetes and rhabdomyolysis.
Rhabdomyolysis is a severe muscle injury that can damage the kidneys.
Lawsuits also mentioned liver damage.
Patients blamed Crestor for severe muscle injuries, diabetes and liver damage.
Accusations Against AstraZeneca
People who filed lawsuits said AstraZeneca knew Crestor was defective and dangerous. They said AstraZeneca failed to warn the public about the risks of taking Crestor.
Lawsuits also accuse the company of deceptively and misleadingly promoting the drug. And they allege AstraZeneca failed to adequately test Crestor.
Please seek the advice of a medical professional before making health care decisions.
Elaine Silvestrini is an award-winning journalist with 30 years of experience covering state and federal court systems. She joined Drugwatch in 2017. Her coverage for Drugwatch has been cited in the CDC’s Public Health Law News and the USA Today Network. Some of her qualifications include:
Centers for Disease Control and Prevention certificates in Health Literacy
Experience as an assistant investigator for the Federal Public Defender
Loyola Law School Journalist Law School Fellowship